← back to search

Carlos Rodríguez‐Galindo

Cincinnati Children's Hospital Medical Center · US
Area of research
Pediatrics, Perinatology and Child Health · Neurology
Research interest
Research interests include Childhood Cancer Survivors' Quality of Life, Neuroblastoma Research and Treatments, Ocular Oncology and Treatments, and Sarcoma Diagnosis and Treatment.
h-index
87
citations
27,824
works
729
NIH funding
primary concept
Medicine
email

Recent publications

Building Pediatric Hematology/Oncology Workforce Capacity in Latin America.
2026cited by 1position: contributordoi
Disease Extent, Not Lesion Location, Determines Relapse Risk in Single-System Skeletal Langerhans Cell Histiocytosis.
2026cited by 0position: contributordoi
Highlights From the 2025 Pediatric Oncology East and Mediterranean Biennial Conference: Advancing Pediatric Oncology Across the Eastern Mediterranean.
2026cited by 0position: contributordoi
Treatment Decision Making at Diagnosis for Children Presenting With Advanced Cancer in Low- and Middle-Income Countries.
2026cited by 0position: contributordoi
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosis.
2026cited by 0position: contributordoi
Reducing the Diagnostic Time for Childhood Cancer in Peru: A Hospital-Based Registry Analysis Four Years After Implementation of the Global Initiative for Childhood Cancer.
2026cited by 0position: contributordoi
The St. Jude Global Academy: A Multifaceted Education Program to Expand Pediatric Oncology Workforce Capacity.
2025cited by 6position: contributordoi
The St. Jude Global Academy: A Multifaceted Education Program to Expand Pediatric Oncology Workforce Capacity
Pediatric Blood & Cancer 2025cited by 6position: lastdoi
One-Two Punch: Combining Chemotherapy and Immunotherapy to Decrease Radiation Dose and Related Toxicity in Children and Adolescents with Nasopharyngeal Carcinoma.
2025cited by 3position: contributordoi
An innovative virtual fellowship leveraging global and regional mentorship to foster pediatric neuro-oncologists in low/middle-income countries
Neuro-Oncology Advances 2025cited by 1position: middledoi
Aliança AMARTE: A Collaborative Network to Improve Oncologic Pediatric Care in Brazil.
2025cited by 1position: contributordoi
Introductory Course in Pediatric Oncology for Registrars/Residents and Medical Officers in Sub-Saharan Africa: A Pilot Study.
2025cited by 0position: contributordoi
Landscape of Global Pediatric Oncology Publications: A Cross-Sectional Analysis.
2025cited by 0position: contributordoi
Outcome of Children With Intermediate-Risk Extracranial Malignant Germ Cell Tumors by Response Status at the End of Induction Chemotherapy: A Report From the Children's Oncology Group.
2025cited by 0position: contributordoi
Adaptive Clinical Neuroblastoma Risk Groups-Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group Project.
2025cited by 0position: contributordoi
Prospective Evaluation of the Pathologic Diagnosis and Treatment Outcomes of Pediatric Burkitt Lymphoma in the Central American Pediatric Hematology-Oncology Association Consortium.
2025cited by 0position: contributordoi
Reducing Diagnostic Time for Childhood Cancer in Peru: A Hospital-Based Registry Analysis Four Years After the Implementation of the Global Initiative for Childhood Cancer
2025cited by 0position: contributordoi
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures
Cancer 2024cited by 20position: middledoi
Stigma in Pediatric Cancer: An Exploratory Study of Osteosarcoma and Retinoblastoma in Guatemala, Jordan, and Zimbabwe.
2024cited by 6position: contributordoi
Unification of Efforts to Improve Global Access to Cancer Therapeutics: Report From the 2022/2023 Access to Essential Cancer Medicines Stakeholder Summit.
2024cited by 6position: contributordoi
The transformation of Cure4Kids: Expanding knowledge transfer capacity.
2024cited by 5position: contributordoi
A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1).
2024cited by 5position: contributordoi
Retrospective comparative analysis of two medical evacuation systems for Ukrainian patients affected by war
European Journal of Cancer 2024cited by 5position: middledoi
Impact of a Regional Pediatric Hematology/Oncology Fellowship Program in Guatemala.
2024cited by 3position: contributordoi
Understanding treatment recommendations at diagnosis of advanced cancer in pediatric oncology: The need to explore decision-making challenges globally.
2024cited by 1position: contributordoi
A regional virtual case discussion forum in pediatric oncology: Experience of the Pediatric Oncology East and Mediterranean Group.
2024cited by 1position: contributordoi
Explanatory models in real-world clinical interactions at a pediatric cancer center in Guatemala.
2024cited by 0position: contributordoi
Parent-provider communication dynamics during the pediatric oncology diagnostic process in Guatemala: A qualitative study.
2024cited by 0position: contributordoi
Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/<i>DICER1</i> Registry.
2023cited by 21position: contributordoi
Collaboration for success: the Global Initiative for Childhood Cancer in Latin America
Revista Panamericana de Salud Pública 2023cited by 17position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 66 papers (2019–2026) · 11 papers (2021–2026)Raul C. Ribeiro · University of Florida10 papers (2021–2024)Dylan E. Graetz · Imperial College London9 papers (2019–2026)Nickhill Bhakta · Disco (Germany)9 papers (2019–2026)A. Lindsay Frazier · Harvard University8 papers (2015–2025)Emilia M. Pinto · St. Jude Children's Research Hospital8 papers (2021–2023)Kim E. Nichols · University of Alabama8 papers (2019–2023)Guillermo Chantada · Universitat de Barcelona8 papers (2021–2026)Ibrahim Qaddoumi · Tennessee Oncology7 papers (2020–2025)Michael Walsh · Cornell University7 papers (2022–2023)Suzanne P. MacFarland · Philadelphia University7 papers (2022–2023)Kelsey Breen · University of Colorado Anschutz Medical Campus7 papers (2022–2023)Kara Maxwell · Cancer Research Center7 papers (2022–2023)Gerard P. Zambetti · SpringerNature7 papers (2022–2023)Maria N. Formiga · Fundação Antônio Prudente7 papers (2022–2023)Roya Mostafavi · St. Jude Children's Research Hospital7 papers (2022–2023) · 7 papers (2020–2025) · 7 papers (2021–2026) · 7 papers (2022–2023)